Subject(s)
Analgesics, Opioid/therapeutic use , COVID-19 , Delivery of Health Care, Integrated/organization & administration , Drug Users , Health Services Accessibility/organization & administration , Opiate Substitution Treatment , Opioid-Related Disorders/rehabilitation , Prisoners , Vulnerable Populations , Analgesics, Opioid/supply & distribution , Drug Prescriptions , Humans , Policy MakingABSTRACT
IMPORTANCE: The recent parenteral opioid shortage (POS) has potential implications for cancer-related pain management in hospitalized patients. OBJECTIVE: This study compared changes in opioid prescriptions and clinically improved pain (CIP) among patients treated by an inpatient palliative care (PC) team before and after our institution first reported the POS. DESIGN, SETTING, AND PARTICIPANTS: A cohort study of 386 eligible patients with cancer treated at a comprehensive cancer center 1 month before and after the announcement of the POS. We reviewed data from electronic health records, including patient demographics, opioid type, route of administration, and dose. Board-certified palliative care specialists assessed CIP at follow-up day 1. EXPOSURES: The announcement of the POS by the institution's pharmacy and therapeutics committee on February 8, 2018. MAIN OUTCOMES AND MEASURES: The primary outcome was to measure the change in opioid prescription patterns of physicians, and the secondary outcome was to measure the proportion of patients who achieved CIP before and after announcement of the POS. RESULTS: Of 386 eligible patients, 196 were men (51%), 270 were white (70%), and the median age was 58 years (interquartile range, 46-67 years). Parenteral opioids were prescribed less frequently by the referring oncology teams after the POS (56 of 314 [18%]) vs before the POS (109 of 311 [35%]) (P < .001). The PC team also prescribed fewer parenteral opioids after the POS (96 of 336 [29%]) vs before the POS (159 of 338 [47%]) (P < .001). After the POS (vs before the POS), significantly fewer patients achieved CIP on follow-up day 1 (119 [62%] vs 144 [75%] of 193; P = .01). Multivariate analysis showed that before the POS, patients had an 89% higher chance of achieving CIP on follow-up day 1 (odds ratio, 1.89; 95% CI, 1.22-2.94; P = .005). CONCLUSIONS AND RELEVANCE: There was a significant change in opioid prescription patterns associated with the POS. Furthermore, after the POS, fewer patients achieved CIP. These factors have potential implications for patient satisfaction and hospital length of stay.
Subject(s)
Analgesics, Opioid/supply & distribution , Analgesics, Opioid/therapeutic use , Cancer Pain/drug therapy , Neoplasms/drug therapy , Practice Patterns, Physicians'/statistics & numerical data , Aged , Cancer Care Facilities , Female , Hospitalization , Hospitals, University , Humans , Infusions, Parenteral , Male , Middle Aged , Pain Management , Palliative Care , Retrospective Studies , Treatment OutcomeSubject(s)
Analgesics, Opioid/supply & distribution , Biological Therapy , Biotechnology , Entrepreneurship , Escherichia coli/metabolism , Printing, Three-Dimensional , Stem Cells/cytology , Stem Cells/drug effects , Tissue Engineering , Analgesics, Opioid/adverse effects , Analgesics, Opioid/economics , Analgesics, Opioid/metabolism , Animals , Bioengineering , Bioreactors , California , Cell Differentiation/drug effects , Drug Evaluation, Preclinical/economics , Drug Evaluation, Preclinical/methods , Drug Industry/trends , Entrepreneurship/economics , Entrepreneurship/organization & administration , Escherichia coli/genetics , Humans , Investments , Metabolism, Inborn Errors/metabolism , Metabolism, Inborn Errors/therapy , Microbiota/genetics , Microbiota/physiology , Muscular Dystrophy, Duchenne/drug therapy , Opioid-Related Disorders/prevention & control , Printing, Three-Dimensional/economics , Printing, Three-Dimensional/instrumentation , Skin , Small Molecule Libraries/pharmacology , Small Molecule Libraries/therapeutic use , Transcription Factors/antagonists & inhibitors , Transcription Factors/metabolismSubject(s)
Analgesics, Opioid/history , Cocaine/history , Drug Prescriptions/history , Heroin/history , Opium/history , Pharmacies/history , Analgesics, Opioid/supply & distribution , Cocaine/supply & distribution , Drug Prescriptions/statistics & numerical data , England , Female , Heroin/supply & distribution , History, 19th Century , History, 20th Century , Humans , Male , Opium/supply & distribution , Sex Characteristics , Socioeconomic FactorsABSTRACT
Access to palliative care is insufficient in many countries around the world. In an effort to improve access to palliative care services and treatments, a public health approach as suggested by the World Health Organization was implemented in Colombia to improve opioid availability, increase awareness and competences about palliative care for healthcare workers, and to include palliative care as a component of care in legislation. As a result, opioid availability has improved, a mandatory palliative care course for medical undergraduate students has been implemented and a palliative care law is being discussed in the Senate. This article describes the strategy, main achievements and suggestions for implementing similar initiatives in developing countries.
Subject(s)
Analgesics, Opioid/supply & distribution , Delivery of Health Care, Integrated/organization & administration , Developing Countries , Palliative Care/organization & administration , Public Health Administration , Colombia , Delivery of Health Care, Integrated/legislation & jurisprudence , Education, Medical, Undergraduate/methods , Education, Medical, Undergraduate/standards , Health Policy , Health Services Accessibility/organization & administration , Humans , International Cooperation , Palliative Care/legislation & jurisprudenceSubject(s)
Neoplasms/complications , Pain Management , Pain/etiology , Analgesics, Opioid/supply & distribution , Analgesics, Opioid/therapeutic use , Australia , Humans , Longitudinal Studies , National Health Programs/economics , National Health Programs/statistics & numerical data , Pain/drug therapySubject(s)
Neoplasms/complications , Pain Management , Pain/etiology , Analgesics, Opioid/supply & distribution , Analgesics, Opioid/therapeutic use , Humans , Ireland , Longitudinal Studies , National Health Programs/statistics & numerical data , National Health Programs/trends , Palliative Care/methods , Palliative Care/statistics & numerical data , Palliative Care/trendsSubject(s)
Neoplasms/complications , Pain Management , Pain/etiology , Analgesics, Opioid/supply & distribution , Analgesics, Opioid/therapeutic use , Chemotherapy, Adjuvant/methods , Chemotherapy, Adjuvant/statistics & numerical data , Humans , Longitudinal Studies , National Health Programs/statistics & numerical data , National Health Programs/trends , New Zealand , Pain/diagnosis , Pain/drug therapy , Pain MeasurementABSTRACT
As in other developed and developing countries, the most common chronic disorders affecting the Chilean population are cardiovascular disease, cancer, cirrhosis, diabetes, chronic obstructive pulmo- nary disease and external injuries. Availability of oncology services is not extensive and there are no academic programs to adequately train practitioners in either palliative medicine or comprehensive palliative care for allied health professionals including nurses, psychologists and chaplains. Major efforts have been made to incorporate palliative care as an important health care focus in the last decade and in the development of effective policies for opioid availability. Chile now meets 84% of the 17 criteria outlined by the World Health Organization and the International Narcotics Control Board for opioid availability. Postgraduate medical education in symptom control, clinical use of opioids and end-of-life care remains relatively poor as judged by the results of a questionnaire administered to 158 resident physicians at the Pontificia Universidad Católica de Chile. Improvements in symptom control and the development of palliative care in Chile will depend on the effective assessment of symptom control effectiveness and improved education and training of health professionals in clinical pharmacology, symptom control, clinical ethics, and end-of-life care.
Subject(s)
Analgesics, Opioid/supply & distribution , Chronic Disease , Health Policy , Palliative Care/methods , Terminal Care/methods , Analgesics, Opioid/therapeutic use , Chile/epidemiology , Chronic Disease/drug therapy , Chronic Disease/mortality , Education, Medical, Graduate , Humans , Internship and Residency , Medical Oncology/education , Morphine/supply & distribution , Morphine/therapeutic use , National Health Programs , Palliative Care/standards , Program Development , Surveys and Questionnaires , Terminal Care/standards , VolunteersABSTRACT
Palliative care started in Hong Kong in 1982. It gradually established an increasingly important role in cancer care. Hong Kong is fortunate because analgesic drugs and expertise from various disciplines and specialties in pain management are readily available. A holistic approach to pain management has been adopted; various dimensions of pain are assessed and managed, and outcomes evaluated. Despite efforts in public education, patient-related barriers to pain management still exist, and it is important that misconceptions of patients be corrected. To promote the quality of palliative care and pain management, efforts have been made to provide training of healthcare professionals, and on formation of professional societies for palliative care doctors and nurses. In Hong Kong, palliative medicine achieved medical specialty status in 1998, with a curriculum and a structured training program designed for doctors interested in this field. Efforts are underway to further improve palliative care and pain management in Hong Kong through the formation of consultative teams in general hospitals, enhanced liaison with nursing homes, and possibly by redefining the role of traditional Chinese medicine in pain management.